Summary
We studied the functional role of angiotensin II (AII) receptor subtypes and vasodilatory endothelial autacoid release in response to AII in isolated perfused rabbit hearts. AII infusion induced biphasic changes in coronary perfusion pressure (CPP): an initial increase was followed by a decrease until a plateau was reached. At higher concentrations of AII (≥10 nmol/l) this plateau phase was lower than the initial CPP level. AII infusion elicited inverse changes in peak left ventricular pressure (LVP): coronary constriction was associated with a transient decline, and during the plateau phase LVP was clearly increased. AII also moderately augmented prostacyclin (PGI2) release from the coronary vascular bed. The AII-induced changes in CPP, LVP, and PGI2 release were effectively inhibited by the AT1 receptor subtype antagonist ICI D8731 (30 nmol/l), but not by the AT2 receptor antagonist CGP 42112 (30 nmol/l). The adenosine A1 receptor antagonist 8-phenyltheophylline (0.1 μmol/l) attenuated the decline in CPP following the constriction phase without affecting the changes in LVP during AII infusion. The cyclooxygenase inhibitor diclofenac (1 mmol/l) had no effect on the AII-induced changes in CPP, whereas the nitric oxide-synthase inhibitor NG-nitro-L-arginine (30 μmol/l) markedly potentiated the vasoconstriction but was without effect on the plateau phase of the response. In contrast to AII, the thromboxane analogue U46619 elicited sustained increases in CPP which were associated with slight decreases in LVP.
In conclusion, AII induced a biphasic pressor response in the rabbit coronary vascular bed consisting of a transient vasoconstriction followed by a dilatation especially at higher concentrations of AII, an effect which was independent of the endothelial autacoids nitric oxide and PGI2. The AII-induced dilatation probably reflected rapid desensitization of the coronary arterial smooth muscle to the constrictor effect, and the concomitant accumulation of vasodilatory metabolites such as adenosine, generated during the positive inotropic action of AII. All the effects of AII in the rabbit heart appeared to be mediated via the AT, receptor subtype localized on coronary endothelial and smooth muscle cells, as well as on cardiomyocytes.
Similar content being viewed by others
References
Andersson KE, Hedlund H, Stahl M (1992) Contractions induced by angiotensin I, angiotensin II and bradykinin in isolated smooth muscle from the human detrusor. Acta Physiol Scand 145:253–259
Baker KM, Khosla M (1986) Cardiac and vascular actions of decapeptide angiotensin analogs. J Pharmacol Exp Ther 239:790–796
Baker KM, Booz GW, Dostal DE (1992) Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol 54:227–241
Bardenheuer H, Whelton B, Sparks HV Jr (1987) Adenosine release by the isolated guinea pig heart in response to isoproterenol, acetylcholine, and acidosis: the minimal role of vascular endothelium. Circ Res 61:594–600
Bruns RF, Lu GH, Pugsley TA (1986) Characterization of the A2 adenosine receptor labelled by [3H]NECA in rat striatal membranes. Mol Pharmacol 29:331–346
Busse R, Mülsch A, Fleming I, Hecker M (1993) Mechanisms of nitric oxide release from the vascular endothelium. Circulation 87[Suppl V]:V-18-V-25
Fenton RA, Dobson JG Jr (1993) Hypoxia enhances isoproterenol-induced increase in heart interstitial adenosine, depressing β-adrenergic contractile responses. Circ Res 72:571–578
Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milstedt A, Tallant EA (1991) Angiotensin-(1–7): a new hormone of the angiotensin system. Hypertension 18[Suppl III]:III-126-III-133
Frediani-Neto E, Silva EG, Paiva TB, Paiva ACM (1991) Increased intracellular Na+ and depolarization favor angiotensin tachyphylaxis in rabbit aorta. Am J Physiol 260(2 Pt 2):H373-H378
Furchgott RF (1984) Role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol 24:175–197
Hecker M, Bara AT, Nestler F, Busse R (1993) Modulation der AT1-Rezeptor-vermittelten vasokonstriktorischen Wirkung von angiotensin II durch endotheliale AT2-rezeptoren. Z Kardiol 82:79
Hirakata H, Fouad-Tarazi FM, Bumpus FM, Khosla n, Healy B, Husain A, Urata H, Kumagai H (1990) Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril. Circ Res 66:891–899
Inagami T, Iwai N, Sasaki K, Yamamo Y, Bardhan S, Chaki S, Guo D-F, Furuta H (1992) Cloning, expression and regulation of angiotensin II receptors. J Hypertens 10:713–716
Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM (1991) The nonpeptide angiotensin II antagonist Dup 753 is a potent stimulus for prostacyclin synthesis. Am J Hypertens 4:228–233
Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, Ferrario CM (1993) Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: Subtypes of angiotensin receptors involved. J Pharmacol Exp Ther 265:664–673
Knape JTA, van Zwieten PA (1988) Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac β1-adrenoceptors. Naunyn Schmiedeberg's Arch Pharmacol 338:185–190
Lamontagne D, Pohl U, Busse R (1991) NG-nitro-l-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart. Pflügers Arch 418:266–270
Lamontagne D, Pohl U, Busse R (1992a) Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 70:123–130
Lamontagne D, Konig A, Bassenge E, Busse R (1992b) Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol 20:652–657
Leung KH, Chang RSL, Lotti VJ, Roscoe WA, Smith RD, Timmermans PBMWM, Chiu AT (1992) AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes. Am J Hypertens 5:648–656
Lew MJ, Duling BR (1992) Access of blood-borne vasoconstrictors to the arteriolar smooth muscle. J Vasc Res 29:341–346
Maigaard S, Forman A, Andersson KE (1986) Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the uteroplacental unit. Acta Physiol Scand 128:23–31
Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142
Myers PR, Minor R Jr, Guerra R Jr, Bates JN, Harrison DG (1990) Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345:161–163
Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ (1993) Differential responses to angiotensin-(1–7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol 234:35–42
Oshiro MEM, Shimuta SI, Paiva TB, Paiva ACM (1989) Evidence for a regulatory site in the angiotensin II receptor of smooth muscle. Eur J Pharmacol 166:411–417
Persson S (1986) Endocrinology of heart failure. Pathophysiologic aspects — hemodynamics. Acta Med Scand 707[Suppl]:7–14
Rogg H, Schmid A, de Gasparo M (1990) Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biophys Biochem Res Commun 173:416–422
Scheuer DA, Perrone MH (1993) Angiotensin type 2 receptors mediate the depressor phase of biphasic response to angiotensin. Am J Physiol 264:R917-R923
Sealy JE, Laragh JH (1990) The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management. Raven Press, New York, pp 1287–1317
Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M (1992) Characterization of angiotensin II receptor subtypes in rat heart. Circ Res 71:1482–1489
Stallone JN, Nishimura H, Nasjletti A (1990) Angiotensin II binding sites in aortic endothelium of domestic fowl. Am J Physiol 258:E777-E782
Timmermans PBMWM, Chin AT, Herblin WF, Wong PC, Smith RD (1992) Angiotensin II receptor subtypes. Am J Hypertens 5:406–410
Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205–251
Toda N (1984) Endothelium-dependent relaxation induced by angiotensin II and histamine in isolated arteries of dog. Br J Pharmacol 81:301–307
Ullian ME, Linas SL (1990) Angiotensin II surface receptor coupling to inositol triphosphate formation in vascular smooth muscle. J Biol Chem 265:195–200
Xiang J-Z, Linz W, Becker H, Ganten D, Lang RE, Schölkens B, Unger T (1985) Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol 113:215–223
Yamaguchi K, Nishimura N (1988) Angiotensin II-induced relaxation of fowl aorta. Am J Physiol 255:R591-R599
Yamazaki M, Toda N (1991) Comparison of responses to angiotensin II of dog mesenteric arteries and veins. Eur J Pharmacol 201:223–229
Zhang J, Pfaffendorf M, van Zwieten PA (1993) Positive inotropic action of angiotensin II in the pithed rat. Naunyn Schmiedeberg's Arch Pharmacol 347:658–663
Author information
Authors and Affiliations
Additional information
On leave from the Department of Biomedical Sciences, University of Tampere, P.O. Box 607, FIN-33101 Tampere, Finland
Correspondence to: I. Pörsti
Rights and permissions
About this article
Cite this article
Pörsti, I., Hecker, M., Bassenge, E. et al. Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 348, 650–658 (1993). https://doi.org/10.1007/BF00167243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00167243